Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Флебит и тромбофлебит поверхностных сосудов

Список литературы

  1. Meissner M.H., Wakefield T.W., Ascher E., Caprini J.A., Comerota A.J., Eklof B., Gillespie D.L., Greenfield L.J., He A.R., Henke P.K., Hingorani A., Hull R.D., Kessler C.M., McBane R.D., McLafferty R. Acute venous disease: venous thrombosis and venous trauma // J. Vasc. Surg. 2007. Т. 46 Suppl S. С. 25S-53S.
  2. Gillet J.L., Perrin M., Cayman R. [Superficial venous thrombosis of the lower limbs: prospective analysis in 100 patients] // J. Mal. Vasc. 2001. Т. 26, № 1. С. 16–22.
  3. Leon L., Giannoukas A.D., Dodd D., Chan P., Labropoulos N. Clinical significance of superficial vein thrombosis // Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2005. Т. 29, № 1. С. 10–17.
  4. Blättler W., Schwarzenbach B., Largiadèr J. Superficial vein thrombophlebitis--serious concern or much ado about little? // VASA Z. Gefasskrankheiten. 2008. Т. 37, № 1. С. 31–38.
  5. Decousus H., Frappé P., Accassat S., Bertoletti L., Buchmuller A., Seffert B., Merah A., Becker F., Queré I., Leizorovicz A. Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs // Best Pract. Res. Clin. Haematol. 2012. Т. 25, № 3. С. 275–284.
  6. Савельев В.С., Кириенко А.И., Золотухин И.А., Селиверстов Е.И. Проспективное обсервационное исследование СПЕКТР: регистр пациентов с хроническими заболеваниями вен нижних конечностей // Флебология. 2012. Т. 6, № 1. С. 4–9.
  7. Jacobsen A.F., Skjeldestad F.E., Sandset P.M. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study // J. Thromb. Haemost. JTH. 2008. Т. 6, № 6. С. 905–912.
  8. Barrellier M.T. [Superficial venous thromboses of the legs] // Phlebologie. 1993. Т. 46, № 4. С. 633–639.
  9. Krause U., Kock H.J., Kröger K., Albrecht K., Rudofsky G. Prevention of deep venous thrombosis associated with superficial thrombophlebitis of the leg by early saphenous vein ligation // VASA Z. Gefasskrankheiten. 1998. Т. 27, № 1. С. 34–38.
  10. Mouton W.G., Kienle Y., Muggli B., Naef M., Wagner H.E. Tumors associated with superficial thrombophlebitis // VASA Z. Gefasskrankheiten. 2009. Т. 38, № 2. С. 167–170.
  11. Engesser L., Broekmans A.W., Briët E., Brommer E.J., Bertina R.M. Hereditary protein S deficiency: clinical manifestations // Ann. Intern. Med. 1987. Т. 106, № 5. С. 677–682.
  12. Pabinger I., Schneider B. Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose- und Hamostaseforschung (GTH) Study Group on Natural Inhibitors // Arterioscler. Thromb. Vasc. Biol. 1996. Т. 16, № 6. С. 742–748.
  13. de Moerloose P., Wutschert R., Heinzmann M., Perneger T., Reber G., Bounameaux H. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight // Thromb. Haemost. 1998. Т. 80, № 2. С. 239–241.
  14. Hanson J.N., Ascher E., DePippo P., Lorensen E., Scheinman M., Yorkovich W., Hingorani A. Saphenous vein thrombophlebitis (SVT): a deceptively benign disease // J. Vasc. Surg. 1998. Т. 27, № 4. С. 677–680.
  15. Martinelli I., Cattaneo M., Taioli E., De Stefano V., Chiusolo P., Mannucci P.M. Genetic risk factors for superficial vein thrombosis // Thromb. Haemost. 1999. Т. 82, № 4. С. 1215–1217.
  16. Schönauer V., Kyrle P.A., Weltermann A., Minar E., Bialonczyk C., Hirschl M., Quehenberger P., Schneider B., Partsch H., Eichinger S. Superficial thrombophlebitis and risk for recurrent venous thromboembolism // J. Vasc. Surg. 2003. Т. 37, № 4. С. 834–838.
  17. de Godoy J.M.P., Braile D.M. Protein S deficiency in repetitive superficial thrombophlebitis // Clin. Appl. Thromb. Off. J. Int. Acad. Clin. Appl. Thromb. 2003. Т. 9, № 1. С. 61–62.
  18. van Langevelde K., Lijfering W.M., Rosendaal F.R., Cannegieter S.C. Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study // Blood. 2011. Т. 118, № 15. С. 4239–4241.
  19. Legnani C., Cini M., Cosmi B., Filippini M., Favaretto E., Palareti G. Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs // Thromb. Haemost. 2014. Т. 111, № 6. С. 1194–1196.
  20. Karathanos C., Exarchou M., Tsezou A., Kyriakou D., Wittens C., Giannoukas A. Factors associated with the development of superficial vein thrombosis in patients with varicose veins // Thromb. Res. 2013. Т. 132, № 1. С. 47–50.
  21. Karathanos C., Spanos K., Saleptsis V., Tsezou A., Kyriakou D., Giannoukas A.D. Recurrence of superficial vein thrombosis in patients with varicose veins // Phlebology. 2016. Т. 31, № 7. С. 489–495.
  22. de Godoy J.M., Batigália F., Braile D.M. Superficial thrombophlebitis and anticardiolipin antibodies--report of association // Angiology. 2001. Т. 52, № 2. С. 127–129.
  23. Di Minno M.N.D., Ambrosino P., Ambrosini F., Tremoli E., Di Minno G., Dentali F. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis // J. Thromb. Haemost. JTH. 2016. Т. 14, № 5. С. 964–972.
  24. Chengelis D.L., Bendick P.J., Glover J.L., Brown O.W., Ranval T.J. Progression of superficial venous thrombosis to deep vein thrombosis // J. Vasc. Surg. 1996. Т. 24, № 5. С. 745–749.
  25. Blumenberg R.M., Barton E., Gelfand M.L., Skudder P., Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis // J. Vasc. Surg. 1998. Т. 27, № 2. С. 338–343.
  26. Dalsing M.C. The case against anticoagulation for superficial venous thrombosis // Dis.--Mon. DM. 2010. Т. 56, № 10. С. 582–589.
  27. Leizorovicz A., Becker F., Buchmüller A., Quéré I., Prandoni P., Decousus H., CALISTO Study Group. Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study // Blood. 2013. Т. 122, № 10. С. 1724–1729.
  28. Гаврилов С.Г., Золотухин И.А., Пустовойт А.А. Приустьевая перевязка магистральной подкожной вены по поводу острого восходящего тромбофлебита // Флебология. 2011. Т. 5, № 4. С. 88–90.
  29. Frappé P., Buchmuller-Cordier A., Bertoletti L., Bonithon-Kopp C., Couzan S., Lafond P., Leizorovicz A., Merah A., Presles E., Preynat P., Tardy B., Décousus H., STEPH Study Group. Annual diagnosis rate of superficial vein thrombosis of the lower limbs: the STEPH community-based study // J. Thromb. Haemost. JTH. 2014. Т. 12, № 6. С. 831–838.
  30. Coon W.W., Willis P.W., Keller J.B. Venous thromboembolism and other venous disease in the Tecumseh community health study // Circulation. 1973. Т. 48, № 4. С. 839–846.
  31. Superficial thrombophlebitis // Handbook of Venous and Lymphatic Disorders. 4th ed. / ed. Gloviczki P. CRC Press, 2017. 343–347 с.
  32. Lutter K.S., Kerr T.M., Roedersheimer L.R., Lohr J.M., Sampson M.G., Cranley J.J. Superficial thrombophlebitis diagnosed by duplex scanning // Surgery. 1991. Т. 110, № 1. С. 42–46.
  33. Decousus H., Quéré I., Presles E., Becker F., Barrellier M.-T., Chanut M., Gillet J.-L., Guenneguez H., Leandri C., Mismetti P., Pichot O., Leizorovicz A., POST (Prospective Observational Superficial Thrombophlebitis) Study Group. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study // Ann. Intern. Med. 2010. Т. 152, № 4. С. 218–224.
  34. Geersing G.-J., Cazemier S., Rutten F., Fitzmaurice D.A., Hoes A.W. Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands // BMJ Open. 2018. Т. 8, № 4. С. e019967.
  35. Kudlaty E., Oriowo B., Yang M.J., Go M.R., Satiani B. Isolated Great Saphenous Vein Thrombus Is Associated with High Rates of Complications regardless of Management // Ann. Vasc. Surg. 2017. Т. 45. С. 154–159.
  36. Binder B., Lackner H.K., Salmhofer W., Kroemer S., Custovic J., Hofmann-Wellenhof R. Association between superficial vein thrombosis and deep vein thrombosis of the lower extremities // Arch. Dermatol. 2009. Т. 145, № 7. С. 753–757.
  37. Galanaud J.-P., Genty C., Sevestre M.-A., Brisot D., Lausecker M., Gillet J.-L., Rolland C., Righini M., Leftheriotis G., Bosson J.-L., Quere I., OPTIMEV SFMV investigators. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study // Thromb. Haemost. 2011. Т. 105, № 1. С. 31–39.
  38. Cannegieter S.C., Horváth-Puhó E., Schmidt M., Dekkers O.M., Pedersen L., Vandenbroucke J.P., Sørensen H.T. Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: a nationwide cohort study // Blood. 2015. Т. 125, № 2. С. 229–235.
  39. Кириенко А.И., Матюшенко А.А., Андрияшкин В.В. Острый тромбофлебит. ЛитТерра, 2006. 109 с.
  40. Marković M.D., Lotina S.I., Davidović L.B., Vojnović B.R., Kostić D.M., Cinara I.S., Svetković S.D. [Acute superficial thrombophlebitis--modern diagnosis and therapy] // Srp. Arh. Celok. Lek. 1997. Т. 125, № 9–10. С. 261–266.
  41. Bauersachs R.M. Diagnosis and treatment of superficial vein thrombosis // Hamostaseologie. 2013. Т. 33, № 3. С. 232–240.
  42. Nasr H., Scriven J.M. Superficial thrombophlebitis (superficial venous thrombosis) // BMJ. 2015. Т. 350. С. h2039.
  43. Стойко Ю.М., Кириенко А.И., Илюхин Е.А., Лобастов К.В., Чаббаров Р.Г., Париков М.А., Хорев Н.Г., Золотухин И.А., Андрияшкин В.В., Карпенко А.А., Фокин А.А., Сушков С.А., Сапелкин С.В., Сучков И.А., Крылов А.Ю., Игнатьев И.М. Диагностика и лечение тромбофлебита поверхностных вен конечностей . Рекомендации Ассоциации флебологов России // Флебология. 2019. Т. 13, № 2. С. 78–97.
  44. Шевченко Ю.Л., Стойко Ю.М. Клиническая флебология. ДПК Пресс. 2016. 256 с.
  45. Савельев В.С., Гологорский В.А., Кириенко А.И., Алексперова В.В., Андрияшкин В.В., Богачев В.Ю., Богданец Л.И., Вирганский А.О., Гельфанд Б.Р., Гологорский В.А., Григорян Р.А., Гриненко Т.Ф., Золотухин И.А., Капранов С.А., Леонтьев С.Г., Матюшенко А.А., Прокубовский В.И. Флебология: руководство для врачей / под ред. Савельев В.С. М.: Медицина, 2001. 664 с.
  46. Caprini J.A., Goldshteyn S., Glase C.J., Hathaway K. Thrombophilia testing in patients with venous thrombosis // Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2005. Т. 30, № 5. С. 550–555.
  47. Karathanos C., Sfyroeras G., Drakou A., Roussas N., Exarchou M., Kyriakou D., Giannoukas A.D. Superficial vein thrombosis in patients with varicose veins: role of thrombophilia factors, age and body mass // Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2012. Т. 43, № 3. С. 355–358.
  48. Kalodiki E., Stvrtinova V., Allegra C., Andreozzi G., Antignani P.-L., Avram R., Brkljacic B., Cadariou F., Dzsinich C., Fareed J., Gaspar L., Geroulakos G., Jawien A., Kozak M., Lattimer C.R., Minar E., Partsch H., Passariello F., Patel M., Pécsvárady Z., Poredos P., Roztocil K., Scuderi A., Sparovec M., Szostek M., Skorski M. Superficial vein thrombosis: a consensus statement // Int. Angiol. J. Int. Union Angiol. 2012. Т. 31, № 3. С. 203–216.
  49. Zygmunt J.A. Duplex ultrasound for chronic venous insufficiency // J. Invasive Cardiol. 2014. Т. 26, № 11. С. E149-155.
  50. Smith Z.T., Bagley A.R., Guy D., Preston L., Ali N.S. Ultrasound Imaging of Superficial Venous Thrombosis in the Upper and Lower Extremities: Closing the Gap Between Clinical Management Guidelines and Ultrasound Practice Parameters // J. Ultrasound Med. 2021. С. 1–8.
  51. Madhusudhana S., Moore A., Moormeier J.A. Current issues in the diagnosis and management of deep vein thrombosis // Mo. Med. 2009. Т. 106, № 1. С. 43–48; quiz 48–49.
  52. Lim K.-E., Hsu W.-C., Hsu Y.-Y., Chu P.-H., Ng C.-J. Deep venous thrombosis: comparison of indirect multidetector CT venography and sonography of lower extremities in 26 patients // Clin. Imaging. 2004. Т. 28, № 6. С. 439–444.
  53. Maki D.D., Kumar N., Nguyen B., Langer J.E., Miller W.T., Gefter W.B. Distribution of thrombi in acute lower extremity deep venous thrombosis: implications for sonography and CT and MR venography // AJR Am. J. Roentgenol. 2000. Т. 175, № 5. С. 1299–1301.
  54. Carpenter J.P., Holland G.A., Baum R.A., Owen R.S., Carpenter J.T., Cope C. Magnetic resonance venography for the detection of deep venous thrombosis: comparison with contrast venography and duplex Doppler ultrasonography // J. Vasc. Surg. 1993. Т. 18, № 5. С. 734–741.
  55. Duwe K.M., Shiau M., Budorick N.E., Austin J.H., Berkmen Y.M. Evaluation of the lower extremity veins in patients with suspected pulmonary embolism: a retrospective comparison of helical CT venography and sonography. 2000 ARRS Executive Council Award I. American Roentgen Ray Society // AJR Am. J. Roentgenol. 2000. Т. 175, № 6. С. 1525–1531.
  56. Kakkos S.K., Gohel M., Baekgaard N., Bauersachs R., Bellmunt-Montoya S., Black S.A., Ten Cate-Hoek A.J., Elalamy I., Enzmann F.K., Geroulakos G., Gottsäter A., Hunt B.J., Mansilha A., Nicolaides A.N., Sandset P.M., Stansby G., Esvs Guidelines Committee  null, de Borst G.J., Bastos Gonçalves F., Chakfé N., Hinchliffe R., Kolh P., Koncar I., Lindholt J.S., Tulamo R., Twine C.P., Vermassen F., Wanhainen A., Document Reviewers  null, De Maeseneer M.G., Comerota A.J., Gloviczki P., Kruip M.J.H.A., Monreal M., Prandoni P., Vega de Ceniga M. Editor’s Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis // Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2021. Т. 61, № 1. С. 9–82.
  57. Cosmi B. Management of superficial vein thrombosis // J. Thromb. Haemost. JTH. 2015. Т. 13, № 7. С. 1175–1183.
  58. Uncu H. A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis // Phlebology. 2009. Т. 24, № 2. С. 56–60.
  59. Superficial Thrombophlebitis Treated By Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis // Arch. Intern. Med. 2003. Т. 163, № 14. С. 1657–1663.
  60. Di Nisio M., Wichers I.M., Middeldorp S. Treatment for superficial thrombophlebitis of the leg // Cochrane Database Syst. Rev. 2018. Т. 2, № 2. С. CD004982.
  61. Rathbun S.W., Aston C.E., Whitsett T.L. A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis // J. Thromb. Haemost. JTH. 2012. Т. 10, № 5. С. 833–839.
  62. Ferrari E., Pratesi C., Scaricabarozzi I. A comparison of nimesulide and diclofenac in the treatment of acute superficial thrombophlebitis // Drugs. 1993. Т. 46 Suppl 1. С. 197–199.
  63. Agus G.B., de Angelis R., Mondani P., Moia R. Double-blind comparison of nimesulide and diclofenac in the treatment of superficial thrombophlebitis with telethermographic assessment // Drugs. 1993. Т. 46 Suppl 1. С. 200–203.
  64. Золкин В.Н., Тищенко И.С. Антикоагулянтная терапия в лечении острых тромбозов глубоких и поверхностных вен нижних конечностей: 15–16 // Трудный Пациент. Россия, Москва: Общество с ограниченной ответственностью «ИД Академиздат», 2007. Т. 5, № 15–16. С. 11–15.
  65. Duffett L., Kearon C., Rodger M., Carrier M. Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis // Thromb. Haemost. 2019. Т. 119, № 3. С. 479–489.
  66. Decousus H., Prandoni P., Mismetti P., Bauersachs R.M., Boda Z., Brenner B., Laporte S., Matyas L., Middeldorp S., Sokurenko G., Leizorovicz A., CALISTO Study Group. Fondaparinux for the treatment of superficial-vein thrombosis in the legs // N. Engl. J. Med. 2010. Т. 363, № 13. С. 1222–1232.
  67. Cosmi B., Filippini M., Tonti D., Avruscio G., Ghirarduzzi A., Bucherini E., Camporese G., Imberti D., Palareti G., STEFLUX Investigators. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum) // J. Thromb. Haemost. JTH. 2012.
  68. Prandoni P., Tormene D., Pesavento R., Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial // J. Thromb. Haemost. JTH. 2005. Т. 3, № 6. С. 1152–1157.
  69. Titon J.P., Auger D., Grange P., Hecquet J.P., Remond A., Ulliac P., Vaissié J.J. [Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with a non-steroidal anti-inflammatory agent] // Ann. Cardiol. Angeiol. (Paris). 1994. Т. 43, № 3. С. 160–166.
  70. Beyer-Westendorf J., Schellong S.M., Gerlach H., Rabe E., Weitz J.I., Jersemann K., Sahin K., Bauersachs R., SURPRISE investigators. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial // Lancet Haematol. 2017. Т. 4, № 3. С. e105–e113.
  71. Cancer-Associated Venous Thromboembolic Disease, Version: 2.2024 [Электронный ресурс] // National Comprehensive Cancer Network (NCCN). 2024. URL: https://www.nccn.org/professionals/physician_gls/pdf/vte.pdf (дата обращения: 27.07.2024).
  72. Sullivan V., Denk P.M., Sonnad S.S., Eagleton M.J., Wakefield T.W. Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous system // J. Am. Coll. Surg. 2001. Т. 193, № 5. С. 556–562.
  73. Пустовойт А.А., Гаврилов С.Г., Золотухин И.А. Тактика лечения острого восходящего тромбофлебита // Флебология. 2011. С. 46–52.
  74. Заболевания вен / под ред. Фронек Х.С. М.: ГЭОТАР-Медиа, 2010. 208 с.
  75. Boehler K., Kittler H., Stolkovich S., Tzaneva S. Therapeutic effect of compression stockings versus no compression on isolated superficial vein thrombosis of the legs: a randomized clinical trial // Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2014. Т. 48, № 4. С. 465–471.
  76. No authors listed. Indomethacin in superficial thrombophlebitis // The Practitioner. 1970. Т. 205, № 227. С. 369–372.
  77. Górski G., Szopiński P., Michalak J., Marianowska A., Borkowski M., Geremek M., Trochimczuk M., Brotánek J., Sárník S., Seménka J., Wilkowski D., Noszczyk W. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis // Angiology. 2005. Т. 56, № 1. С. 9–17.
  78. Vilardell M., Sabat D., Arnaiz J.A., Bleda M.J., Castel J.M., Laporte J.R., Vallvé C. Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter. A double-blind, randomized, placebo-controlled trial // Eur. J. Clin. Pharmacol. 1999. Т. 54, № 12. С. 917–921.
  79. Bergqvist D., Brunkwall J., Jensen N., Persson N.H. Treatment of superficial thrombophlebitis. A comparative trial between placebo, Hirudoid cream and piroxicam gel // Ann. Chir. Gynaecol. 1990. Т. 79, № 2. С. 92–96.
  80. Belcaro G., Cesarone M.R., Dugall M., Feragalli B., Ippolito E., Corsi M., Hosoi M., Cornelli U., Ledda A., Gizzi G., Luzzi R., Georgiev M. Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study // Panminerva Med. 2011. Т. 53, № 3 Suppl 1. С. 3–11.
  81. Katzenschlager R., Hirschl M., Minar E., Ugurluoglu A. Liposomal heparin-spraygel in comparison with subcutaneous low molecular weight heparin in patients with superficial venous thrombosis. A randomized, controlled, open multicentre study // J. Kardiologie. 2003. Т. 10, № 9. С. 375–378.
  82. Becherucci A., Bagilet D., Marenghini J., Diab M., Biancardi H. [Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion] // Med. Clin. (Barc.). 2000. Т. 114, № 10. С. 371–373.
  83. De Sanctis M.T., Cesarone M.R., Incandela L., Belcaro G., Griffin M. Treatment of superficial vein thrombosis with standardized application of Essaven gel--a placebo-controlled, randomized study // Angiology. 2001. Т. 52 Suppl 3. С. S57-62.
  84. Incandela L., De Sanctis M.T., Cesarone M.R., Ricci A., Errichi B.M., Dugal M., Belcaro G., Griffin M. Treatment of superficial vein thrombosis: clinical evaluation of Essaven gel--a placebo-controlled, 8-week, randomized study // Angiology. 2001. Т. 52 Suppl 3. С. S69-72.
  85. Sharma A. Effectiveness of Cold Application, Heparinoid Application and Megnesium-sulphate Application on Superficial Thrombophlebitis-Literature Review // Int. J. Nurs. Educ. 2016. Т. 8, № 2. С. 1.
  86. Sharma A. A comparative study to assess the effectiveness of cold application heparinoid application and magnesium sulphate application on superficial thrombophlebitis among patients admitted in selected hospital of Gujarat // Int. J. Nurs. Educ. 2016. Т. 8. С. 118–121.
  87. Бокерия Л.А., Затевахин И.И., Кириенко А.И. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений // Флебология. 2015. Т. 4, № 2. С. 2–25.
  88. Giannoukas A., Karathanos C., Nikolakopoulos K., Georgiadis G.S., Maltezos C., Ioannou C., Vasdekis S., Trelopoulos G., SeVEN Collaborators. Tinzaparin in intermediate dose for the treatment of superficial vein thrombosis: Results from an observational multicenter study-SeVEN study // Phlebology. 2018. Т. 33, № 9. С. 636–645.
  89. Lobastov K., Schastlivtsev I., Bargandzhiya A., Stepanov E. The Association between Anticoagulation Duration and the Risk of Venous Thromboembolism in Patients with Lower Limb Superficial Vein Thrombosis: A Systematic Review and Meta-analysis // J Vasc Surg Venous Lymphat Disord. 2022. Т. 10, № 2. С. 561.
  90. Quenet S., Laroche J.-P., Bertoletti L., Quéré I., Décousus H., Becker F., Leizorovicz A. Value of a planned compression ultrasonography after an isolated superficial vein thrombosis: results from a prospective multicentre study // Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2012. Т. 43, № 2. С. 233–237.
  91. Marchiori A., Verlato F., Sabbion P., Camporese G., Rosso F., Mosena L., Andreozzi G.M., Prandoni P. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study // Haematologica. 2002. Т. 87, № 5. С. 523–527.
  92. Stevens S.M., Woller S.C., Kreuziger L.B., Bounameaux H., Doerschug K., Geersing G.-J., Huisman M.V., Kearon C., King C.S., Knighton A.J., Lake E., Murin S., Vintch J.R.E., Wells P.S., Moores L.K. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report // Chest. 2021. Т. 160, № 6. С. e545–e608.
  93. Gillet J.L., Allaert F.A., Perrin M. [Superficial thrombophlebitis in non varicose veins of the lower limbs. A prospective analysis in 42 patients] // J. Mal. Vasc. 2004. Т. 29, № 5. С. 263–272.
  94. Cosmi B., Filippini M., Campana F., Avruscio G., Ghirarduzzi A., Bucherini E., Camporese G., Imberti D., Legnani C., Palareti G., STEFLUX Investigators. Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum) // Thromb. Res. 2014. Т. 133, № 2. С. 196–202.
  95. Barco S., Pomero F., Di Minno M.N.D., Tamborini Permunian E., Malato A., Pasca S., Barillari G., Fenoglio L., Siragusa S., Di Minno G., Ageno W., Dentali F. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study // J. Thromb. Haemost. JTH. 2017. Т. 15, № 11. С. 2176–2183.
  96. Di Nisio M., Peinemann F., Porreca E., Rutjes A.W.S. Treatment for superficial infusion thrombophlebitis of the upper extremity // Cochrane Database Syst. Rev. 2015. Т. 2015, № 11. С. CD011015.
  97. Lipe D.N., Afzal M., King K.C. Septic Thrombophlebitis [Электронный ресурс] // StatPearls [Internet]. 2024. URL: https://www.ncbi.nlm.nih.gov/books/NBK430731/ (дата обращения: 26.07.2024).
  98. Chirinos J.A., Garcia J., Alcaide M.L., Toledo G., Baracco G.J., Lichtstein D.M. Septic thrombophlebitis: diagnosis and management // Am. J. Cardiovasc. Drugs Drugs Devices Interv. 2006. Т. 6, № 1. С. 9–14.
  99. Яковлев С., Журавлева М., Проценко Д., Белобородов В., Брико Н., Брусина Е., Гусаров В., Елисеева Е., Замятин М., Зырянов С. Программа СКАТ (Стратегия Контроля Антимикробной Терапии) при оказании стационарной медицинской помощи // Cons. Medicum. 2017. Т. 19, № 7–1. С. 15–51.
  100. Mezon B.J., Voitk A.J. Septic superficial thrombophlebitis: a major threat from a minor lesion // Can. Med. Assoc. J. 1976. Т. 114, № 12. С. 1128–1132.
  101. Andes D.R., Urban A.W., Acher C.W., Maki D.G. Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter // Am. J. Med. 1998. Т. 105, № 5. С. 446–450.
  102. Mailhe M., Aubry C., Brouqui P., Michelet P., Raoult D., Parola P., Lagier J.-C. Complications of peripheral venous catheters: The need to propose an alternative route of administration // Int. J. Antimicrob. Agents. 2020. Т. 55, № 3. С. 105875.
  103. Cesarone M.R., Belcaro G., Agus G., Georgiev M., Errichi B.M., Marinucci R., Errichi S., Filippini A., Pellegrini L., Ledda A., Vinciguerra G., Ricci A., Cipollone G., Lania M., Gizzi G., Ippolito E., Bavera P., Fano F., Dugall M., Adovasio R., Gallione L., Del Boccio G., Cornelli U., Steigerwalt R., Acerbi G., Cacchio M., Di Renzo A., Hosoi M., Stuard S., Corsi M., Di Ciano L., Simeone E., Collevecchio G., Grossi M.G., Di Giambattista F., Carestia F., Zukowski A. Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document // Angiology. 2007. Т. 58 Suppl 1. С. 7S-14S.
  104. Maeseneer M.G.R.De. Superficial Thrombophlebitis of the Lower Limb : Practical Recommendations for Diagnosis and Treatment Superficial Thrombophlebitis of the Lower Limb : Practical Recommendations // Acta Chir Belg. 2016. № March. С. 145–147.
  105. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O’Fallon W.M., Melton L.J. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study // Arch. Intern. Med. 2000. Т. 160, № 6. С. 809–815.
  106. Bauersachs R., Gerlach H.E., Heinken A., Hoffmann U., Langer F., Noppeney T., Pittrow D., Klotsche J., Rabe E. Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT) // Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2021. Т. 62, № 2. С. 241–249.
  107. Wiegers H.M.G., Körmendiné Farkas D., Horváth-Puhó E., Middeldorp S., van Es N., Sørensen H.T. Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period: a Danish nationwide cohort study // Lancet Haematol. 2023. Т. 10, № 5. С. e359–e366.
  108. Royal College of Obstetricians and Gynaecologists. Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management. RCOG Green-top Guideline No. 37b. 2015 [Электронный ресурс] // RCOG. URL: green-top-guidelines/thrombosis-and-embolism-during-pregnancy-and-the-puerperium-acute-management-green-top-guideline-no-37b/ (дата обращения: 27.07.2024).
  109. Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium. RCOG Green-top Guideline No. 37a. 2015 [Электронный ресурс] // RCOG. URL: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/reducing-the-risk-of-thrombosis-and-embolism-during-pregnancy-and-the-puerperium-green-top-guideline-no-37a/ (дата обращения: 27.07.2024).
  110. Bates S.M., Rajasekhar A., Middeldorp S., McLintock C., Rodger M.A., James A.H., Vazquez S.R., Greer I.A., Riva J.J., Bhatt M., Schwab N., Barrett D., LaHaye A., Rochwerg B. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy // Blood Adv. 2018. Т. 2, № 22. С. 3317–3359.
  111. Bates S.M., Middeldorp S., Rodger M., James A.H., Greer I. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism // J. Thromb. Thrombolysis. 2016. Т. 41, № 1. С. 92–128.
  112. Сухих Г.Т., et al. Профилактика венозных тромбоэмболических осложнений в акушерстве и гинекологии. Клинические рекомендации (протокол) // Акушерство И Гинекология. 2014. Т. 10. С. 1–18.
  113. Bates S.M., Greer I.A., Middeldorp S., Veenstra D.L., Prabulos A.-M., Vandvik P.O. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines // Chest. 2012. Т. 141, № 2 Suppl. С. e691S-e736S.
  114. Roach R.E.J., Lijfering W.M., van Hylckama Vlieg A., Helmerhorst F.M., Rosendaal F.R., Cannegieter S.C. The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors // Blood. 2013. Т. 122, № 26. С. 4264–4269.
  115. Antic D., Lefkou E., Otasevic V., Banfic L., Dimakakos E., Olinic D., Milić D., Miljić P., Xhepa S., Stojkovski I., Kozak M., Dimulescu D.R., Preradović T.K., Nancheva J., Pazvanska E.E., Tratar G., Gerotziafas G.T. Position Paper on the Management of Pregnancy-Associated Superficial Venous Thrombosis. Balkan Working Group for Prevention and Treatment of Venous Thromboembolism // Clin. Appl. Thromb. Off. J. Int. Acad. Clin. Appl. Thromb. 2022. Т. 28. С. 1076029620939181.
  116. Aaro L.A., Johnson T.R., Juergens J.L. Acute superficial venous thrombophlebitis associated with pregnancy // Am. J. Obstet. Gynecol. 1967. Т. 97, № 4. С. 514–518.
  117. Heit J.A., Kobbervig C.E., James A.H., Petterson T.M., Bailey K.R., Melton L.J. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study // Ann. Intern. Med. 2005. Т. 143, № 10. С. 697–706.
  118. Jacobsen A.F., Skjeldestad F.E., Sandset P.M. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study // Am. J. Obstet. Gynecol. 2008. Т. 198, № 2. С. 233.e1-7.
  119. Pomp E.R., Lenselink A.M., Rosendaal F.R., Doggen C.J.M. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study // J. Thromb. Haemost. JTH. 2008. Т. 6, № 4. С. 632–637.
  120. Romualdi E., Dentali F., Rancan E., Squizzato A., Steidl L., Middeldorp S., Ageno W. Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature // J. Thromb. Haemost. JTH. 2013. Т. 11, № 2. С. 270–281.
  121. Linnemann B., Scholz U., Rott H., Halimeh S., Zotz R., Gerhardt A., Toth B., Bauersachs R., Working Group in Women’s Health of the Society of Thrombosis and Hemostasis. Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women’s Health of the Society of Thrombosis and Haemostasis (GTH) // VASA Z. Gefasskrankheiten. 2016. Т. 45, № 2. С. 103–118.
  122. Sanson B.J., Lensing A.W., Prins M.H., Ginsberg J.S., Barkagan Z.S., Lavenne-Pardonge E., Brenner B., Dulitzky M., Nielsen J.D., Boda Z., Turi S., Mac Gillavry M.R., Hamulyák K., Theunissen I.M., Hunt B.J., Büller H.R. Safety of low-molecular-weight heparin in pregnancy: a systematic review // Thromb. Haemost. 1999. Т. 81, № 5. С. 668–672.
  123. Warkentin T.E., Levine M.N., Hirsh J., Horsewood P., Roberts R.S., Gent M., Kelton J.G. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin // N. Engl. J. Med. 1995. Т. 332, № 20. С. 1330–1335.
  124. Weitz J.I. Low-molecular-weight heparins // N. Engl. J. Med. 1997. Т. 337, № 10. С. 688–698.
  125. Greer I.A., Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy // Blood. 2005. Т. 106, № 2. С. 401–407.
  126. Lepercq J., Conard J., Borel-Derlon A., Darmon J.Y., Boudignat O., Francoual C., Priollet P., Cohen C., Yvelin N., Schved J.F., Tournaire M., Borg J.Y. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies // BJOG Int. J. Obstet. Gynaecol. 2001. Т. 108, № 11. С. 1134–1140.
  127. Pettilä V., Leinonen P., Markkola A., Hiilesmaa V., Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin // Thromb. Haemost. 2002. Т. 87, № 2. С. 182–186.
  128. Carlin A.J., Farquharson R.G., Quenby S.M., Topping J., Fraser W.D. Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control // Hum. Reprod. Oxf. Engl. 2004. Т. 19, № 5. С. 1211–1214.
  129. Rodger M.A., Kahn S.R., Cranney A., Hodsman A., Kovacs M.J., Clement A.M., Lazo-Langner A., Hague W.M., TIPPS investigators. Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial // J. Thromb. Haemost. JTH. 2007. Т. 5, № 8. С. 1600–1606.
  130. Byrd L.M., Shiach C.R., Hay C.R.M., Johnston T.A. Osteopenic fractures in pregnancy: is low molecular weight heparin (LMWH) implicated? // J. Obstet. Gynaecol. J. Inst. Obstet. Gynaecol. 2008. Т. 28, № 5. С. 539–542.
  131. Le Templier G., Rodger M.A. Heparin-induced osteoporosis and pregnancy // Curr. Opin. Pulm. Med. 2008. Т. 14, № 5. С. 403–407.
  132. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy // Obstet. Gynecol. 2018. Т. 132, № 1. С. e1–e17.
  133. Jacobson B., Rambiritch V., Paek D., Sayre T., Naidoo P., Shan J., Leisegang R. Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis // Adv. Ther. 2020. Т. 37, № 1. С. 27–40.
  134. Moodley O., Pearson D., Goubran H. Anticoagulation in Pregnancy and Lactation // Precision Anticoagulation Medicine / под ред. Goubran H., Ragab G., Hassouna S. Cham: Springer International Publishing, 2020. С. 147–157.
  135. Tang A.-W., Greer I. A systematic review on the use of new anticoagulants in pregnancy // Obstet. Med. 2013. Т. 6, № 2. С. 64–71.
  136. Bapat P., Pinto L.S.R., Lubetsky A., Berger H., Koren G. Rivaroxaban transfer across the dually perfused isolated human placental cotyledon // Am. J. Obstet. Gynecol. 2015. Т. 213, № 5. С. 710.e1-6.
  137. Nakhai-Pour H.R., Broy P., Sheehy O., Bérard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion // CMAJ Can. Med. Assoc. J. J. Assoc. Medicale Can. 2011. Т. 183, № 15. С. 1713–1720.
  138. Nielsen G.L., Sørensen H.T., Larsen H., Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study // BMJ. 2001. Т. 322, № 7281. С. 266–270.
  139. Nielsen G.L., Skriver M.V., Pedersen L., Sørensen H.T. Danish group reanalyses miscarriage in NSAID users // BMJ. 2004. Т. 328, № 7431. С. 109.
  140. Li D.-K., Liu L., Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study // BMJ. 2003. Т. 327, № 7411. С. 368.
  141. Edwards D.R.V., Aldridge T., Baird D.D., Funk M.J., Savitz D.A., Hartmann K.E. Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion // Obstet. Gynecol. 2012. Т. 120, № 1. С. 113–122.
  142. MHRA Drug Safety Update [Электронный ресурс] // MHRA Medicines and Health Regulatory Agency. URL: http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate (accessed: 09.10.2020) (дата обращения: 26.07.2024).
  143. Rigourd V., de Villepin B., Amirouche A., Bruneau A., Seraissol P., Florent A., Urien S., Magny J.-F., Serreau R. Ibuprofen concentrations in human mature milk--first data about pharmacokinetics study in breast milk with AOR-10127 «Antalait» study // Ther. Drug Monit. 2014. Т. 36, № 5. С. 590–596.
  144. Stanley A.Y., Durham C.O., Sterrett J.J., Wallace J.B. Safety of Over-the-Counter Medications in Pregnancy // MCN. Am. J. Matern. Child Nurs. 2019. Т. 44, № 4. С. 196–205.
  145. FDA Pregnancy Categories [Электронный ресурс] // drugs.com. URL: https://www.drugs.com/pregnancy-categories.html (дата обращения: 26.07.2024).
  146. Briggs G. Acetaminophen // Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 12-е изд. Lippincott Williams & Wilkins, 2021. С. 1461.
  147. Stergiakouli E., Thapar A., Davey Smith G. Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding // JAMA Pediatr. 2016. Т. 170, № 10. С. 964–970.
  148. Ito S., Blajchman A., Stephenson M., Eliopoulos C., Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication // Am. J. Obstet. Gynecol. 1993. Т. 168, № 5. С. 1393–1399.
  149. Temprano K.K., Bandlamudi R., Moore T.L. Antirheumatic drugs in pregnancy and lactation // Semin. Arthritis Rheum. 2005. Т. 35, № 2. С. 112–121.
  150. Østensen M.E. Safety of Non-Steroidal Anti-Inflammatory Drugs during Pregnancy and Lactation // Side Effects of Anti-Inflammatory Drugs IV / под ред. Rainsford K.D. Dordrecht: Springer, 1997.
  151. Spigset O., Hägg S. Analgesics and breast-feeding: safety considerations // Paediatr. Drugs. 2000. Т. 2, № 3. С. 223–238.
  152. Janssen N.M., Genta M.S. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation // Arch. Intern. Med. 2000. Т. 160, № 5. С. 610–619.
  153. National Institute of Child Health and Human Development. Ibuprofen [Электронный ресурс] // Drugs and Lactation Database. URL: https://www.ncbi.nlm.nih.gov/books/NBK500986/ (дата обращения: 27.07.2024).
  154. Berlin C.M., Yaffe S.J., Ragni M. Disposition of acetaminophen in milk, saliva, and plasma of lactating women // Pediatr. Pharmacol. N. Y. N. 1980. Т. 1, № 2. С. 135–141.
  155. Bitzén P.O., Gustafsson B., Jostell K.G., Melander A., Wåhlin-Boll E. Excretion of paracetamol in human breast milk // Eur. J. Clin. Pharmacol. 1981. Т. 20, № 2. С. 123–125.
  156. Findlay J.W., DeAngelis R.L., Kearney M.F., Welch R.M., Findlay J.M. Analgesic drugs in breast milk and plasma // Clin. Pharmacol. Ther. 1981. Т. 29, № 5. С. 625–633.
  157. Sachs H.C., Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics // Pediatrics. 2013. Т. 132, № 3. С. e796-809.
  158. National Institute of Child Health and Human Development. Acetaminophen [Электронный ресурс] // Drugs and Lactation Database. URL: https://www.ncbi.nlm.nih.gov/books/NBK501194/ (дата обращения: 27.07.2024).
  159. Aminoshariae A., Kulild J.C., Donaldson M. Short-term use of nonsteroidal anti-inflammatory drugs and adverse effects: An updated systematic review // J. Am. Dent. Assoc. 1939. 2016. Т. 147, № 2. С. 98–110.
  160. Roberge S., Giguère Y., Villa P., Nicolaides K., Vainio M., Forest J.-C., von Dadelszen P., Vaiman D., Tapp S., Bujold E. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis // Am. J. Perinatol. 2012. Т. 29, № 7. С. 551–556.
  161. Poon L.C., Shennan A., Hyett J.A., Kapur A., Hadar E., Divakar H., McAuliffe F., da Silva Costa F., von Dadelszen P., McIntyre H.D., Kihara A.B., Di Renzo G.C., Romero R., D’Alton M., Berghella V., Nicolaides K.H., Hod M. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention // Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet. 2019. Т. 145 Suppl 1, № Suppl 1. С. 1–33.
  162. Datta P., Rewers-Felkins K., Kallem R.R., Baker T., Hale T.W. Transfer of Low Dose Aspirin Into Human Milk // J. Hum. Lact. Off. J. Int. Lact. Consult. Assoc. 2017. Т. 33, № 2. С. 296–299.
  163. Breastfeeding and maternal medication. Recommendations for drugs in the eleventh WHO model list of essential drugs. World Health Organization, 2002. 35 с.
  164. Flessa H.C., Kapstrom A.B., Glueck H.I., Will J.J. Placental transport of heparin // Am. J. Obstet. Gynecol. 1965. Т. 93, № 4. С. 570–573.
  165. Clark N.P., Delate T., Witt D.M., Parker S., McDuffie R. A descriptive evaluation of unfractionated heparin use during pregnancy // J. Thromb. Thrombolysis. 2009. Т. 27, № 3. С. 267–273.
  166. Ginsberg J.S., Kowalchuk G., Hirsh J., Brill-Edwards P., Burrows R. Heparin therapy during pregnancy. Risks to the fetus and mother // Arch. Intern. Med. 1989. Т. 149, № 10. С. 2233–2236.
  167. Galanaud J.-P., Blaise S., Sevestre M.-A., Terrisse H., Pernod G., Gaillard C., Genty C., Monreal M., Rabah Y., Kahn S.R., Quéré I., Bosson J.-L., OPTIMEV-SFMV investigators. Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer // Thromb. Res. 2018. Т. 171. С. 179–186.
  168. Ploton G., Pistorius M.-A., Raimbeau A., Denis Le Seve J., Bergère G., Ngohou C., Goueffic Y., Artifoni M., Durant C., Gautier G., Connault J., Espitia O. A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis // Medicine (Baltimore). 2020. Т. 99, № 6. С. e18996.
  169. Сомонова О.В., Антух Э.А., Долгушин Б.И., Елизарова А.Л., Сельчук В.Ю., Черкасов В.А. Практические рекомендации по профилактике и лечению тромбоэмболических осложнений у онкологических больных. // Злокачественные Опухоли Практические Рекомендации RUSSCO. 2019. Т. 9, № 3s2. С. 668–677.
  170. Сушинская Т.В., Стуклов Н.И., Доброхотова Ю.Э. Гемостаз и рак-ассоциированный тромбоз: современная профилактика и лечение // Онкология Журнал Им ПА Герцена. 2018. Т. 7, № 4. С. 64–72.
  171. Wang G., Li Y., Wu C., Guo L., Hao L., Liao H., Xiao X., Liu S., Luo L. The clinical features and related factors of PICC-related upper extremity asymptomatic venous thrombosis in cancer patients: A prospective study // Medicine (Baltimore). 2020. Т. 99, № 12. С. e19409.
  172. Streiff M.B., Holmstrom B., Angelini D., Ashrani A., Bockenstedt P.L., Chesney C., Fanikos J., Fenninger R.B., Fogerty A.E., Gao S., Goldhaber S.Z., Gundabolu K., Hendrie P., Lee A.I., Lee J.T., Mann J., McMahon B., Millenson M.M., Morton C., Ortel T.L., Ozair S., Paschal R., Shattil S., Siddiqi T., Smock K.J., Soff G., Wang T.-F., Williams E., Zakarija A., Hammond L., Dwyer M.A., Engh A.M. NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 // J Natl Compr Canc Netw. 2018. Т. 16, № 11. С. 1289–1303.
  173. Dammacco F., Vacca A., Procaccio P., Ria R., Marech I., Racanelli V. Cancer-related coagulopathy (Trousseau’s syndrome): review of the literature and experience of a single center of internal medicine // Clin. Exp. Med. 2013. Т. 13, № 2. С. 85–97.
  174. Mate-Kole M.O., Nkrumah K. Thrombophlebitis migrans as a marker of malignancy // East Afr. Med. J. 1986. Т. 63, № 9. С. 610–612.
  175. Воробьев А.В., Макацария А.Д., Чабров А.М., Савченко А.А. Синдром Труссо: современный взгляд на проблему // Журнал Акушерства И Женских Болезней. 2015. Т. 64, № 4. С. 85–94.
  176. Fazeli B., Modaghegh H., Ravrai H., Kazemzadeh G. Thrombophlebitis migrans as a footprint of Buerger’s disease: a prospective-descriptive study in north-east of Iran // Clin. Rheumatol. 2008. Т. 27, № 1. С. 55–57.
  177. Зербино Д., Зимба Е., Багрий Н. Облитерирующий тромбангиит (болезнь Бюргера): современное состояние проблемы // Ангиология И Сосудистая Хирургия. 2016. Т. 22, № 4. С. 390–395.
  178. Mondor H. Tronculite sous-cutanée subaiguë de la paroi thoraccique antero-laterale // Mem Acad Chir. 1939. Т. 65. С. 1271–1278.
  179. Cervellin G., Creta M., Riva M., Di Comite V., Buttarelli L., Lippi G. Abdominal Mondor’s disease presenting as acute abdominal pain // Acta Bio-Medica Atenei Parm. 2013. Т. 84, № 2. С. 155–158.
  180. Hou M.F., Huang C.J., Huang Y.S., Hsieh J.S., Chan H.M., Wang J.Y., Chuang C.H., Chen F.M., Huang T.J. Mondor’s disease in the breast // Kaohsiung J. Med. Sci. 1999. Т. 15, № 11. С. 632–639.
  181. Pasta V., D’Orazi V., Sottile D., Del Vecchio L., Panunzi A., Urciuoli P. Breast Mondor’s disease: Diagnosis and management of six new cases of this underestimated pathology // Phlebology. 2015. Т. 30, № 8. С. 564–568.
  182. Pugh C.M., DeWitty R.L. Mondor’s disease // J. Natl. Med. Assoc. 1996. Т. 88, № 6. С. 359–363.
  183. Amano M., Shimizu T. Mondor’s Disease: A Review of the Literature // Intern. Med. Tokyo Jpn. 2018. Т. 57, № 18. С. 2607–2612.
  184. Kearon C., Ginsberg J.S., Julian J.A., Douketis J., Solymoss S., Ockelford P., Jackson S., Turpie A.G., MacKinnon B., Hirsh J., Gent M., Fixed-Dose Heparin (FIDO) Investigators. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism // JAMA. 2006. Т. 296, № 8. С. 935–942.
  185. Eck R.J., Bult W., Wetterslev J., Gans R.O.B., Meijer K., Keus F., van der Horst I.C.C. Intermediate Dose Low-Molecular-Weight Heparin for Thrombosis Prophylaxis: Systematic Review with Meta-Analysis and Trial Sequential Analysis // Semin. Thromb. Hemost. 2019. Т. 45, № 8. С. 810–824.
  186. Belcaro G., Nicolaides A.N., Errichi B.M., Cesarone M.R., De Sanctis M.T., Incandela L., Venniker R. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study // Angiology. 1999. Т. 50, № 7. С. 523–529.
  187. Simes J., Becattini C., Agnelli G., Eikelboom J.W., Kirby A.C., Mister R., Prandoni P., Brighton T.A., INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism). Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration // Circulation. 2014. Т. 130, № 13. С. 1062–1071.
  188. Weitz J.I., Lensing A.W.A., Prins M.H., Bauersachs R., Beyer-Westendorf J., Bounameaux H., Brighton T.A., Cohen A.T., Davidson B.L., Decousus H., Freitas M.C.S., Holberg G., Kakkar A.K., Haskell L., van Bellen B., Pap A.F., Berkowitz S.D., Verhamme P., Wells P.S., Prandoni P., EINSTEIN CHOICE Investigators. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism // N. Engl. J. Med. 2017. Т. 376, № 13. С. 1211–1222.
  189. Messa G., La Placa G., Puccetti L., Di Perri T. [Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide] // Minerva Cardioangiol. 1997. Т. 45, № 4. С. 147–153.
  190. Andreozzi G.M., Bignamini A.A., Davì G., Palareti G., Matuška J., Holý M., Pawlaczyk-Gabriel K., Džupina A., Sokurenko G.Y., Didenko Y.P., Andrei L.D., Lessiani G., Visonà A., SURVET Study Investigators. Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial // Circulation. 2015. Т. 132, № 20. С. 1891–1897.
  191. Errichi B.M., Cesarone M.R., Belcaro G., Marinucci R., Ricci A., Ippolito A., Brandolini R., Vinciguerra G., Dugall M., Felicita A., Pellegrini L., Gizzi G., Ruffini M., Acerbi G., Bavera P., Renzo A.D., Corsi M., Scoccianti M., Hosoi M., Lania M. Prevention of recurrent deep venous thrombosis with sulodexide: the SanVal registry // Angiology. 2004. Т. 55, № 3. С. 243–249.
  192. Paraskevas K.I., Nicolaides A.N., Mikhailidis D.P. Statins and venous thromboembolism: the jury is still out // Angiology. 2013. Т. 64, № 7. С. 489–491.
  193. Enas E.A., Kuruvila A., Khanna P., Pitchumoni C.S., Mohan V. Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes // Indian J. Med. Res. 2013. Т. 138, № 4. С. 461–491.
  194. Squizzato A., Galli M., Romualdi E., Dentali F., Kamphuisen P.W., Guasti L., Venco A., Ageno W. Statins, fibrates, and venous thromboembolism: a meta-analysis // Eur. Heart J. 2010. Т. 31, № 10. С. 1248–1256.
  195. Kunutsor S.K., Seidu S., Khunti K. Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies // Eur. Heart J. 2017. Т. 38, № 20. С. 1608–1612.
  196. Кириенко А.И. Острый варикотромбофлебит: диагностика, основные принципы лечения и профилактика // РМЖ. 1999. Т. 13. С. 600.
  197. Sheikh P., Lohsiriwat V., Shelygin Y. Micronized Purified Flavonoid Fraction in Hemorrhoid Disease: A Systematic Review and Meta-Analysis // Adv. Ther. 2020. Т. 37, № 6. С. 2792–2812.
  198. Nocker W., Diebschlag W., Lehmacher W. The efficacy of a diclofenac gel compared with placebo and heparin gel in the local treatment of superficial thrombophlebitis // Z Allg Med. 1991. Т. 67. С. 2214–2222.
  199. Winter W., Klotten K., Arnold S., Babiak D., Stoinder B. Local therapy of thrombophlebitis-superficialis-an interindividual comparison of voltaren emulgel versus a heparin-containing gel // Z Rheumatol. 1986. Т. 45, № 4. С. 180–181.
  200. Holzgreve A., Kleine W., Stegmann W. Local treatment of superficial thrombophlebitis with nonsteroidal antiinflammatory agents // ZFA. 1989. Т. 65, № 27. С. 663–667.
  201. Кургинян Х.М., Раскин В.В. Эндоваскулярное лечение острого тромбофлебита вен нижних конечностей у пациентов с варикозной болезнью // Хирургия Журнал Им НИ Пирогова. 2019. Т. 10. С. 50–54.
  202. Rohrbach N., Mouton W.G., Naef M., Otten K.T., Zehnder T., Wagner H.E. Morbidity in superficial thrombophlebitis and its potential surgical prevention // Swiss Surg. Schweiz. Chir. Chir. Suisse Chir. Svizzera. 2003. Т. 9, № 1. С. 15–17.
  203. Шабунин А., Гаврилов С., Пустовойт С., Бычкова Т., Каралкин А., Золотухин И. Сравнение эффективности хирургической и консервативной тактики при остром восходящем варикотромбофлебите большой подкожной вены бедра // Флебология. 2013. Т. 7, № 2. С. 10–14.
  204. Швальб П., Качинский А., Нарижный М. Флебоцентез — миниинвазивный способ лечения острого тромбофлебита подкожных вен // Флебология. 2009. Т. 3, № 3. С. 23–25.
  205. Enzler M.A., Russell D., Schimmelpfennig J. Thermal ablation in the management of superficial thrombophlebitis // Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2012. Т. 43, № 6. С. 726–728.
  206. Приказ Министерства здравоохранения Российской Федерации № 395н от 21 июня 2013 г. N 395н «Об утверждении норм лечебного питания» [Электронный ресурс] // minzdrav.gov.ru. URL: https://minzdrav.gov.ru/documents/5399-prikaz-minzdrava-ros- (дата обращения: 27.07.2024).
  207. Приказ Министерства здравоохранения Российской Федерации от 23.09.2020 № 1008н «Об утверждении порядка обеспечения пациентов лечебным питанием» (Зарегистрирован 30.09.2020 № 60137) [Электронный ресурс] // Официальное опубликование правовых актов. URL: http://publication.pravo.gov.ru/document/0001202010010037 (дата обращения: 27.07.2024).
  208. Приказ Министерства здравоохранения Российской Федерации от 5 августа 2003 г. N 330 "О мерах по совершенствованию лечебного питания в лечебно-профилактических учреждениях Российской Федерации [Электронный ресурс] // rospotrebnadzor.ru. URL: https://10.rospotrebnadzor.ru/upload/medialibrary/78d/prikaz-minzdrava-rf-ot-05.08.2003-_330.pdf (дата обращения: 27.07.2024).
  209. Figueiredo R.S., Stansby G., Bhattacharya V. Primary prevention of venous thromboembolism // Phlebology. 2012. Т. 27 Suppl 2, № SUPPL.2. С. 23–32.
  210. Chang S.-L., Huang Y.-L., Lee M.-C., Hu S., Hsiao Y.-C., Chang S.-W., Chang C.J., Chen P.-C. Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease // JAMA. 2018. Т. 319, № 8. С. 807–817.
  211. Clarke M.J., Broderick C., Hopewell S., Juszczak E., Eisinga A. Compression stockings for preventing deep vein thrombosis in airline passengers // Cochrane Database Syst. Rev. 2016. № 9. С. 50.
  212. Galanaud J.-P., Sevestre M.-A., Pernod G., Kahn S.R., Genty C., Terrisse H., Brisot D., Gillet J.-L., Quéré I., Bosson J.-L. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis // J. Thromb. Haemost. JTH. 2017. Т. 15, № 6. С. 1123–1131.
  213. Jiang Q.-J., Bai J., Jin J., Shi J., Qu L. Sulodexide for Secondary Prevention of Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis // Front. Pharmacol. 2018. Т. 9. С. 876.
  214. Brighton T.A., Eikelboom J.W., Mann K., Mister R., Gallus A., Ockelford P., Gibbs H., Hague W., Xavier D., Diaz R., Kirby A., Simes J., ASPIRE Investigators. Low-dose aspirin for preventing recurrent venous thromboembolism // N. Engl. J. Med. 2012. Т. 367, № 21. С. 1979–1987.
  215. Wang K.-L., van Es N., Cameron C., Castellucci L.A., Büller H.R., Carrier M. Extended treatment of venous thromboembolism: a systematic review and network meta-analysis // Heart Br. Card. Soc. 2019. Т. 105, № 7. С. 545–552.
  216. Vasanthamohan L., Boonyawat K., Chai-Adisaksopha C., Crowther M. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis // J. Thromb. Haemost. JTH. 2018. Т. 16, № 7. С. 1288–1295.
  217. Galanaud J.P., Bosson J.L., Genty C., Presles E., Cucherat M., Sevestre M.A., Quere I., Decousus H., Leizorovicz A. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies // J. Thromb. Haemost. JTH. 2012. Т. 10, № 6. С. 1004–1011.
  218. Quenet S., Laporte S., Décousus H., Leizorovicz A., Epinat M., Mismetti P., STENOX Group. Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis // J. Vasc. Surg. 2003. Т. 38, № 5. С. 944–949.
  219. Camporese G., Bernardi E., Noventa F. Update on the clinical use of the low-molecular-weight heparin, parnaparin // Vasc. Health Risk Manag. 2009. Т. 5. С. 819–831.
  220. Mitić G., Kovac M., Povazan L., Djordjević V., Ilić V., Salatić I., Lazić R., Antonijević N., Novakov-Mikić A. Efficacy and safety of nadroparin and unfractionated heparin for the treatment of venous thromboembolism during pregnancy and puerperium // Srp. Arh. Celok. Lek. 2010. Т. 138 Suppl 1. С. 18–22.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*